SEC Form 4 · accession 0001209191-16-130585
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent Standridge
Officer — Chief Operating Officer
Period of report
Jul 1, 2016
Accepted (ET)
Jul 1, 2016 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2016 | A | 41,667 | $0.00 | A | 66,667 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.46 | Jul 1, 2016 | A | 83,333 | A | — | Jun 30, 2026 | Common Stock | 83,333 | 83,333 | D |
Explanation of responses
- F1Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on July 1, 2017 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on July 1, 2020, subject to continued service with the Issuer through the applicable vesting dates.